| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Adage Capital Management, L.P.
|
149.711k | 0.92% | — | Mar 31 2026 |
| 2 |
Perceptive Advisors LLC
|
86.666k | 0.53% | — | Mar 31 2026 |
| 3 |
Geode Capital Management, L.L.C.
|
73.880k | 0.46% | +51.790k | Mar 31 2026 |
| 4 |
Citadel Advisors LLC
|
57.363k | 0.35% | +57.363k | Mar 31 2026 |
| 5 |
XTX Markets LLC
|
24.363k | 0.15% | +24.363k | Mar 31 2026 |
|
1
Adage Capital Management, L.P.
|
0.92%
149.711k
|
|
2
Perceptive Advisors LLC
|
0.53%
86.666k
|
|
3
Geode Capital Management, L.L.C.
|
0.46%
73.880k
|
|
4
Citadel Advisors LLC
|
0.35%
57.363k
|
|
5
XTX Markets LLC
|
0.15%
24.363k
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 2.42% of Ensysce Biosciences Inc, with Adage Capital Management, L.P. the biggest at 0.92%, followed by Perceptive Advisors LLC (0.53%) and Geode Capital Management, L.L.C. (0.46%). |
| Short interest shows what share of a stock's freely tradable shares (float) is currently sold short, meaning held by investors betting on falling prices. A high or rising level can be read two ways: it reflects the skepticism of many market participants, but also carries upside potential. Because if the stock rises, short sellers have to buy back, which can push the price up even further. This effect is called a short squeeze. | |
| The short interest in Ensysce Biosciences Inc has fallen over the past 12 months from around 12.7% to 7.3% of the float. Fewer and fewer market participants are betting on falling prices. That points to easing skepticism, as short sellers increasingly unwind their positions. |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


